InvestorsObserver is giving Acasti Pharma Inc (ACST) an Analyst Rating Rank of 74, meaning ACST is ranked higher by analysts than 74% of stocks. The average price target for ACST is $6 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating ACST a Strong Buy today. Find out what this means to you and get the rest of the rankings on ACST!